- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05321355
Mainz Register of Patients With Sleep Disorders (MAINZ-SLEEPREG)
September 11, 2022 updated by: Dr. Yaroslav Winter, Johannes Gutenberg University Mainz
Study on Disease Course and Quality of Life in Patients With Sleep Disorders (Mainz Sleep Registry)
Prospective longitudinal observational registry study of all patients with sleep disorders treated in the Mainz Comprehensive Epilepsy and Sleep Medicine Center with the focus on the course of the disease and quality of life.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Clinical parameters of patients, such as onset of the disease, prior medication, disease severity, which are important for the data analysis also collected retrospectively before the initiation of the registry.
Data on the quality of life is collected only prospectively
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rheinland-Pfalz
-
Mainz, Rheinland-Pfalz, Germany, 55131
- Recruiting
- Mainz Comprehensive Epilepsy and Sleep Medicine Center
-
Contact:
- Winter Yaroslav, MD, MSc
- Phone Number: +496131172234
- Email: yaroslav.winter@unimedizin-mainz.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 120 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All patients treated in Mainz Comprehensive Epilepsy and Sleep Medicine Center
Description
Inclusion Criteria:
- patients with narcolepsy
- patients with other neurological sleep disorders
Exclusion Criteria:
- patients aged <18 years
- patients who cannot provide informed consent and don't have a legal guardian
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patient with narcolepsy treated with vagus nerve stimulation
|
no interventions, only observation
|
Patient without narcolepsy treated with vagus nerve stimulation
|
no interventions, only observation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
European Quality of Life 5 dimensions Index (EQ 5D Index)
Time Frame: 6 months
|
health-related quality of life measured by EQ5D-Index (European Quality of Life 5 dimensions), rating from 0 (worst possible state) to 1 (best possible state)
|
6 months
|
Excessive daytime sleepiness (EDS) as measure by Epworth Sleepiness Scale (ESS) after 3 months (rating from 0 (no sleepiness) to 24 (severe sleepiness))
Time Frame: 3 months
|
EDS measure by ESS at the follow-up after 3 months
|
3 months
|
European Quality of Life 5 dimensions Index (EQ 5D Index)
Time Frame: 3 months
|
health-related quality of life measured by EQ5D-Index (European Quality of Life 5 dimensions), rating from 0 (worst possible state) to 1 (best possible state)
|
3 months
|
Excessive daytime sleepiness (EDS) as measure by Epworth Sleepiness Scale (ESS) after 6 months
Time Frame: 6 months
|
EDS measure by ESS at the follow-up after 6 months (rating from 0 (no sleepiness) to 24 (severe sleepiness))
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Berlin Social Support Scales (BSSS)
Time Frame: 12 months
|
Berlin Social Support Scales (BSSS) is used to assess the amount of emotional, informational and instrumental support received by patients: Total scores ranged from 15 to 60, higher scores identify better support
|
12 months
|
World Health Organization Quality of Life-BREF (WHOQOL-BREF)
Time Frame: 12 months
|
World Health Organization Quality of Life-BREF (WHOQOL-BREF), a scale to assess overall quality of life with a range 0-100 (higher scores correspond better quality of life)
|
12 months
|
Pittsburgh Sleep Quality Index
Time Frame: 12 months
|
Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances, scoring between 0 and 21 with higher scores corresponding to worse sleep quality
|
12 months
|
Multidimensional Fatigue Inventory
Time Frame: 3 months
|
Multidimensional Fatigue Inventory: 20-item self-report instrument designed to measure fatigue.
Measures range from 0-100, representing more severe fatigue at higher scores
|
3 months
|
Multidimensional Fatigue Inventory
Time Frame: 6 months
|
Multidimensional Fatigue Inventory: 20-item self-report instrument designed to measure fatigue.
Measures range from 0-100, representing more severe fatigue at higher scores
|
6 months
|
Beck Depression Inventory II
Time Frame: 6 months
|
Beck Depression Inventory II: higher scores correspond to more severe depression (range 0-63)
|
6 months
|
Beck Depression Inventory II
Time Frame: 12 months
|
Beck Depression Inventory II: higher scores correspond to more severe depression (range
|
12 months
|
Resilience Scale 13
Time Frame: 6 months
|
Resilience Scale 13 (short version with 13 questions): 13-66 points correspond with low resilience, 67-72 with moderate and 73-91 with high resilience
|
6 months
|
Resilience Scale 13
Time Frame: 12 months
|
Resilience Scale 13 (short version with 13 questions): 13-66 points correspond with low
|
12 months
|
European Quality of Life visual analogue scale (EQ-VAS)
Time Frame: 6 months
|
European Quality of Life visual analogue scale (EQ-VAS) (ranges from 0 to 100, where 0 is the worst anf 100 the best state)
|
6 months
|
European Quality of Life visual analogue scale (EQ-VAS)
Time Frame: 12 months
|
European Quality of Life visual analogue scale (EQ-VAS) (ranges from 0 to 100, where 0 is the worst anf 100 the best state)
|
12 months
|
Ullanlinna Narcolepsy Scale (UNS)
Time Frame: 3 months
|
scale to identify the burden of narcolepsy
|
3 months
|
Ullanlinna Narcolepsy Scale (UNS)
Time Frame: 6 months
|
scale to identify the burden of narcolepsy
|
6 months
|
World Health Organization Quality of Life-BREF (WHOQOL-BREF)
Time Frame: 6 months
|
World Health Organization Quality of Life-BREF (WHOQOL-BREF), a scale to assess overall quality of life with a range 0-100 (higher scores correspond better quality of life)
|
6 months
|
Pittsburgh Sleep Quality Index
Time Frame: 6 months
|
Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances, scoring between 0 and 21 with higher scores corresponding to worse sleep quality
|
6 months
|
Berlin Social Support Scales (BSSS)
Time Frame: 6 months
|
Berlin Social Support Scales (BSSS) is used to assess the amount of emotional, informational and instrumental support received by patients: Total scores ranged from 15 to 60, higher scores identify better support
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Anticipated)
January 31, 2030
Study Completion (Anticipated)
January 31, 2030
Study Registration Dates
First Submitted
April 4, 2022
First Submitted That Met QC Criteria
April 4, 2022
First Posted (Actual)
April 11, 2022
Study Record Updates
Last Update Posted (Actual)
September 15, 2022
Last Update Submitted That Met QC Criteria
September 11, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Sleep Disorders, Intrinsic
- Dyssomnias
- Neurologic Manifestations
- REM Sleep Parasomnias
- Sleep Arousal Disorders
- Disease
- Sleep Wake Disorders
- Restless Legs Syndrome
- Mental Disorders
- Parasomnias
- Disorders of Excessive Somnolence
- REM Sleep Behavior Disorder
- Narcolepsy
- Somnambulism
- Idiopathic Hypersomnia
Other Study ID Numbers
- MAINZ-SLEEPREG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disorder
-
Matrouh UniversitySuez Canal University; Beni-Suef University; University of Bisha, Saudia ArabiaCompletedSleep Disorder | Sleep Hygiene | Sleep Disorder; Insomnia Type | Sleep Disorder in Elderly | Sleep Disorder, Mental Health | Sleep Disorders, Physical HealthEgypt
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedSleep Disorder | Diarrhea | Anxiety Disorders | Insomnia | Sleep Initiation and Maintenance Disorders | Anxiety | Sleep Disturbance | Gastrointestinal Dysfunction | Heartburn | Caffeine | Caffeine Withdrawal | Caffeine; Sleep Disorder | Caffeine Dependence | Caffeine-Induced Anxiety Disorder | Caffeine-Induced Sleep... and other conditionsUnited States
-
Yale UniversityCompletedCircadian Rhythm Sleep Disorder, UnspecifiedUnited States
-
The University of Texas Health Science Center,...Active, not recruitingRapid Eye Movement Sleep Behavior DisorderUnited States
-
Merck Sharp & Dohme LLCCompletedDyssomnias | Sleep Disorders | Mental Disorder | Sleep Initiation and Maintenance Disorder; Elderly | Sleep Disorder, Intrinsic
-
Vanda PharmaceuticalsRecruitingSleep Disorder | Sleep Disturbance | Autism Spectrum Disorder | Neurological DisorderUnited States
-
Assistance Publique Hopitaux De MarseilleAix Marseille UniversitéRecruitingREM Sleep Behaviour DisorderFrance
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCritical Illness | Sleep Deprivation | Circadian Rhythm Sleep Disorder, UnspecifiedUnited States
-
Massachusetts General HospitalRecruitingRapid Eye Movement Sleep Behavior DisorderUnited States
-
Federal University of Minas GeraisHarvard Medical School (HMS and HSDM)Active, not recruitingDepressive Disorder | Quality of Life | Sleep Disorder | Anxiety Disorders | Insomnia | Spirituality | Stress Disorder | Insomnia Chronic | Insomnia Disorder | Complementary TherapyBrazil
Clinical Trials on Implantation of vagus nerve stimulation according to clinical indication
-
University Hospital TuebingenUniversität TübingenCompleted
-
University of MinnesotaRecruitingDepressive Disorder | EpilepsyUnited States
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
BioControl MedicalCompleted
-
Duke UniversityEnrolling by invitation
-
Sinop UniversityCompletedHealthy | Activity, MotorTurkey
-
Massachusetts General HospitalNational Institute on Aging (NIA)Recruiting
-
University Hospital, Basel, SwitzerlandCompleted
-
University Hospital, GrenobleCompletedSurgery | Partial EpilepsyFrance
-
Casa Colina Hospital and Centers for HealthcareCompletedCognitive Dysfunction | Post COVID-19United States